Picture of Geneuro SA logo

GNRO — Geneuro SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: Geneuro Cash Position Of 10.1 Million Euros At June 30

July 18 (Reuters) - GENEURO SA  GNRO.PA :
    * CASH POSITION OF EUR 10.1 MILLION AT JUNE 30, 2019
    * SUCCESSFUL FINAL 12-MONTH RESULTS FROM PHASE 2A TYPE 1
DIABETES
TRIAL
    * CONSTRUCTIVE PARTNERING DISCUSSIONS FOR LEAD PRODUCT
TEMELIMAB
CONTINUING, FOLLOWING POSITIVE RESULTS FROM ANGEL-MS
    * COMPANY RECOGNIZED NO REVENUES IN Q2 OF 2019
    * AVAILABLE CASH RESOURCES PROVIDE GENEURO WITH SOLID
FINANCIAL
VISIBILITY UNTIL MID-2020 COVERING ALL PLANNED ACTIVITIES
    * COMPANY RECOGNIZED NO REVENUES IN Q2 OF 2019.

Source text for Eikon:  ID:nBw4PNr0Na 
Further company coverage:  GNRO.PA 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com;))

Recent news on Geneuro SA

See all news